Breaking Business News | Breaking business news AM | Breaking Business News PM

Investors cheer as two coronavirus vaccine candidates report T-cell responses, but findings are still early stage

20 Jul 2020

At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a more durable form of immunity than an antibody response.


Read the full article here.
This content was originally published by MarketWatch.com - Top Stories. Original publishers retain all rights. It appears here for a limited time before automated archiving. By MarketWatch.com - Top Stories

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.

Download